99 related articles for article (PubMed ID: 17466494)
21. Repetitive transcranial magnetic stimulation in bulimia nervosa: preliminary results of a single-centre, randomised, double-blind, sham-controlled trial in female outpatients.
Walpoth M; Hoertnagl C; Mangweth-Matzek B; Kemmler G; Hinterhölzl J; Conca A; Hausmann A
Psychother Psychosom; 2008; 77(1):57-60. PubMed ID: 18087209
[TBL] [Abstract][Full Text] [Related]
22. Psychological vulnerability differences in students--carriers or not of the serotonin transporter promoter allele S: effect of adverse experiences.
Veletza S; Samakouri M; Emmanouil G; Trypsianis G; Kourmouli N; Livaditis M
Synapse; 2009 Mar; 63(3):193-200. PubMed ID: 19086091
[TBL] [Abstract][Full Text] [Related]
23. [The efficacy of transcranial magnetic stimulation in the treatment of depression].
Zyss T; Zieba A; Dudek D; Datka W; Siwek M; Wróbel A; Grabski B; Maczka G; Brudkiewicz P; Wojnar N; Łaczyrska M; Borowiecka-Kluza J; Zygmuntowicz M; Polański A
Przegl Lek; 2010; 67(9):666-73. PubMed ID: 21387802
[TBL] [Abstract][Full Text] [Related]
24. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.
Hong CJ; Chen TJ; Yu YW; Tsai SJ
Pharmacogenomics J; 2006; 6(1):27-33. PubMed ID: 16302021
[TBL] [Abstract][Full Text] [Related]
25. Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression.
Frodl T; Koutsouleris N; Bottlender R; Born C; Jäger M; Mörgenthaler M; Scheuerecker J; Zill P; Baghai T; Schüle C; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
Mol Psychiatry; 2008 Dec; 13(12):1093-101. PubMed ID: 19008895
[TBL] [Abstract][Full Text] [Related]
26. 5-HT1A receptor gene C -1019 G polymorphism and amygdala volume in borderline personality disorder.
Zetzsche T; Preuss UW; Bondy B; Frodl T; Zill P; Schmitt G; Koutsouleris N; Rujescu D; Born C; Reiser M; Möller HJ; Meisenzahl EM
Genes Brain Behav; 2008 Apr; 7(3):306-13. PubMed ID: 18387137
[TBL] [Abstract][Full Text] [Related]
27. Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1.
Secher A; Bukh J; Bock C; Koefoed P; Rasmussen HB; Werge T; Kessing LV; Mellerup E
Int Clin Psychopharmacol; 2009 Jul; 24(4):199-203. PubMed ID: 19474754
[TBL] [Abstract][Full Text] [Related]
28. The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder.
Ferreira Ade A; Neves FS; da Rocha FF; Silva GS; Romano-Silva MA; Miranda DM; De Marco L; Correa H
J Affect Disord; 2009 Jan; 112(1-3):267-72. PubMed ID: 18534687
[TBL] [Abstract][Full Text] [Related]
29. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
[TBL] [Abstract][Full Text] [Related]
30. No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter.
Kellner M; Demiralay C; Muhtz C; Husemann J; Kölsch W; Hiemke C; Yassouridis A; Wiedemann K
Psychiatry Res; 2008 Dec; 161(3):339-43. PubMed ID: 18962988
[TBL] [Abstract][Full Text] [Related]
31. Association between 5-hydroxytryptamine 1A receptor gene polymorphism and suicidal behavior.
Sawiniec J; Borkowski K; Ginalska G; Lewandowska-Stanek H
Przegl Lek; 2007; 64(4-5):208-11. PubMed ID: 17724868
[TBL] [Abstract][Full Text] [Related]
32. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B
Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076
[TBL] [Abstract][Full Text] [Related]
33. Serotonin transporter gene and response to lithium augmentation in depression.
Stamm TJ; Adli M; Kirchheiner J; Smolka MN; Kaiser R; Tremblay PB; Bauer M
Psychiatr Genet; 2008 Apr; 18(2):92-7. PubMed ID: 18349701
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation at a HTR1A polymorphism associated with mental illness.
Le François B; Czesak M; Steubl D; Albert PR
Neuropharmacology; 2008 Nov; 55(6):977-85. PubMed ID: 18639564
[TBL] [Abstract][Full Text] [Related]
35. Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients.
Brakemeier EL; Wilbertz G; Rodax S; Danker-Hopfe H; Zinka B; Zwanzger P; Grossheinrich N; Várkuti B; Rupprecht R; Bajbouj M; Padberg F
J Affect Disord; 2008 May; 108(1-2):59-70. PubMed ID: 17963846
[TBL] [Abstract][Full Text] [Related]
36. Genetics of Lesch's typology of alcoholism.
Samochowiec J; Kucharska-Mazur J; Grzywacz A; Pelka-Wysiecka J; Mak M; Samochowiec A; Bienkowski P
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):423-7. PubMed ID: 17928119
[TBL] [Abstract][Full Text] [Related]
37. Interaction between SERTPR and stressful life events on response to antidepressant treatment.
Mandelli L; Marino E; Pirovano A; Calati R; Zanardi R; Colombo C; Serretti A
Eur Neuropsychopharmacol; 2009 Jan; 19(1):64-7. PubMed ID: 18815011
[TBL] [Abstract][Full Text] [Related]
38. Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: pharmacogenetic, endocrine and psychobehavioral results.
Wong WM; Hasemann S; Schwarz M; Zill P; Koller G; Soyka M; Preuss UW
Pharmacopsychiatry; 2008 Mar; 41(2):72-8. PubMed ID: 18311688
[TBL] [Abstract][Full Text] [Related]
39. A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression.
Fitzgerald PB; Sritharan A; Daskalakis ZJ; de Castella AR; Kulkarni J; Egan G
J Clin Psychopharmacol; 2007 Oct; 27(5):488-92. PubMed ID: 17873682
[TBL] [Abstract][Full Text] [Related]
40. Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in healthy people.
Walderhaug E; Magnusson A; Neumeister A; Lappalainen J; Lunde H; Refsum H; Landrø NI
Biol Psychiatry; 2007 Sep; 62(6):593-9. PubMed ID: 17544379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
